Net profit increases for Celon Pharma

According to a market filing, Celon Pharma reported a net profit of PLN 35.07 million in Q1 - Q3. This compared with PLN 29.9 million profit a year earlier, the company said in its press release. Its revenues were also up marginally – to PLN 81.24 million, compared with PLN 77.55 million during the same period in 2015. Celon Pharma is an integrated biopharmaceutical company that conducts research on pharmaceutical products and also manufactures and sells them. It recently made its debut on the main market of the Warsaw Stock Exchange, in October 2016.